| 2025年年报 | 2025年中报 | 2024年年报 | 2024年中报 | |
|---|---|---|---|---|
| 营业收入(元) | ||||
| 经营租赁(元) | - | 3,521,015.38 | - | 3,682,585.45 |
| 药品销售(元) | - | 27,598,681.11 | - | 52,666,391.73 |
| 风湿类(元) | 33,564,118.19 | - | 29,665,520.07 | - |
| 胃肠类(元) | 12,538,708.44 | - | 19,773,593.81 | - |
| 眼科类(元) | 9,895,583.86 | - | 9,320,977.73 | - |
| 其他药品(元) | 11,124,109.62 | - | 25,456,640.68 | - |
| 营业成本(元) | ||||
| 经营租赁(元) | - | 265,046.57 | - | 535,522.16 |
| 药品销售(元) | - | 21,104,482.55 | - | 31,023,376.96 |
| 风湿类(元) | 3,689,418.69 | - | 23,326,338.69 | - |
| 胃肠类(元) | 11,212,608.47 | - | 10,926,043.01 | - |
| 眼科类(元) | 3,521,247.43 | - | 6,057,238.73 | - |
| 其他药品(元) | 16,467,856.52 | - | 20,279,299.92 | - |
| 毛利(元) | ||||
| 经营租赁(元) | - | 3,255,968.81 | - | 3,147,063.29 |
| 药品销售(元) | - | 6,494,198.56 | - | 21,643,014.77 |
| 风湿类(元) | 29,874,699.50 | - | 6,339,181.38 | - |
| 胃肠类(元) | 1,326,099.97 | - | 8,847,550.80 | - |
| 眼科类(元) | 6,374,336.43 | - | 3,263,739.00 | - |
| 其他药品(元) | -5,343,746.90 | - | 5,177,340.76 | - |
| 毛利率(%) | ||||
| 经营租赁(%) | - | 92.47 | - | 85.46 |
| 药品销售(%) | - | 23.53 | - | 41.09 |
| 风湿类(%) | 89.01 | - | 21.37 | - |
| 胃肠类(%) | 10.58 | - | 44.74 | - |
| 眼科类(%) | 64.42 | - | 35.01 | - |
| 其他药品(%) | -48.04 | - | 20.34 | - |
| 收入构成(%) | ||||
| 经营租赁(%) | - | 11.31 | - | 6.54 |
| 药品销售(%) | - | 88.69 | - | 93.46 |
| 风湿类(%) | 50.00 | - | 35.23 | - |
| 胃肠类(%) | 18.68 | - | 23.48 | - |
| 眼科类(%) | 14.74 | - | 11.07 | - |
| 其他药品(%) | 16.57 | - | 30.23 | - |
| 毛利构成(%) | ||||
| 经营租赁(%) | - | 33.39 | - | 12.69 |
| 药品销售(%) | - | 66.61 | - | 87.31 |
| 风湿类(%) | 92.69 | - | 26.83 | - |
| 胃肠类(%) | 4.11 | - | 37.45 | - |
| 眼科类(%) | 19.78 | - | 13.81 | - |
| 其他药品(%) | -16.58 | - | 21.91 | - |